Home/Filings/4/0001209191-18-003918
4//SEC Filing

ABBOT STEWART 4

Accession 0001209191-18-003918

CIK 0001434316other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 4:05 PM ET

Size

5.5 KB

Accession

0001209191-18-003918

Insider Transaction Report

Form 4
Period: 2018-01-16
ABBOT STEWART
Chief Development Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-01-16+186,000186,000 total
    Exercise: $6.55Exp: 2028-01-15Common Stock (186,000 underlying)
Footnotes (2)
  • [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022.
  • [F2]Not applicable.

Issuer

FATE THERAPEUTICS INC

CIK 0001434316

Entity typeother

Related Parties

1
  • filerCIK 0001655597

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:05 PM ET
Size
5.5 KB